CLIA lab

CLIA 17D2026252: Cooper Drug, Inc

Augusta, KS. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 17D2026252 belongs to Cooper Drug, Inc in Augusta, KS.

Certificate of Waiver, effective April 21, 2026, expires April 20, 2028.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
April 21, 2026
Certificate expiration
April 20, 2028
Status in the CMS file
Active (termination code 00)
Original participation date
June 28, 2011
Facility type
Pharmacy
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
17D2026252
Lab name
Cooper Drug, Inc
Address
509 State Street, Augusta, KS 67010
Phone
(316) 775-2289
Fax
(316) 775-2280

Annual test volume the lab reported

Waived tests
200

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in Augusta, KS

Related

Questions

What is the CLIA number for Cooper Drug, Inc in Augusta?

17D2026252, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Cooper Drug, Inc hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 17D2026252 expire?

The CMS file lists April 20, 2028 as the certificate expiration date; the certificate took effect April 21, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.